TP53 and melanoma: Chen found in human melanoma cells that silencing iPLA2β would enhance the sensitivity to p53-mediated ferroptosis without significant effects on cells that usually express iPLA2β, suggesting that iPLA2β can inhibit p53-mediated ferroptosis, and p53-driven ferroptosis is independent of GPX4 [41].